Report Detail
COVID-19 Impact on Global Durvalumab Market Insights, Forecast to 2026
- RnM3987139 |
- 04 June, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Durvalumab market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Durvalumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Durvalumab market is segmented into
2.4mL Injection
10mL Injection
Segment by Application, the Durvalumab market is segmented into
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other
Regional and Country-level Analysis
The Durvalumab market is analysed and market size information is provided by regions (countries).
The key regions covered in the Durvalumab market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Durvalumab Market Share Analysis
Durvalumab market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Durvalumab business, the date to enter into the Durvalumab market, Durvalumab product introduction, recent developments, etc.
The major vendors covered:
Medimmune (AstraZeneca)
...
1 Study Coverage
- 1.1 Durvalumab Product Introduction
- 1.2 Market Segments
- 1.3 Key Durvalumab Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Durvalumab Market Size Growth Rate by Type
- 1.4.2 2.4mL Injection
- 1.4.3 10mL Injection
- 1.5 Market by Application
- 1.5.1 Global Durvalumab Market Size Growth Rate by Application
- 1.5.2 Locally Advanced Urothelial Carcinoma
- 1.5.3 Metastatic Urothelial Carcinoma
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Durvalumab Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Durvalumab Industry
- 1.6.1.1 Durvalumab Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Durvalumab Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Durvalumab Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Durvalumab Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Durvalumab Market Size Estimates and Forecasts
- 2.1.1 Global Durvalumab Revenue 2015-2026
- 2.1.2 Global Durvalumab Sales 2015-2026
- 2.2 Durvalumab Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Durvalumab Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Durvalumab Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Durvalumab Competitor Landscape by Players
- 3.1 Durvalumab Sales by Manufacturers
- 3.1.1 Durvalumab Sales by Manufacturers (2015-2020)
- 3.1.2 Durvalumab Sales Market Share by Manufacturers (2015-2020)
- 3.2 Durvalumab Revenue by Manufacturers
- 3.2.1 Durvalumab Revenue by Manufacturers (2015-2020)
- 3.2.2 Durvalumab Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Durvalumab Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Durvalumab Revenue in 2019
- 3.2.5 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Durvalumab Price by Manufacturers
- 3.4 Durvalumab Manufacturing Base Distribution, Product Types
- 3.4.1 Durvalumab Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Durvalumab Product Type
- 3.4.3 Date of International Manufacturers Enter into Durvalumab Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Durvalumab Market Size by Type (2015-2020)
- 4.1.1 Global Durvalumab Sales by Type (2015-2020)
- 4.1.2 Global Durvalumab Revenue by Type (2015-2020)
- 4.1.3 Durvalumab Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Durvalumab Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Durvalumab Sales Forecast by Type (2021-2026)
- 4.2.2 Global Durvalumab Revenue Forecast by Type (2021-2026)
- 4.2.3 Durvalumab Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Durvalumab Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Durvalumab Market Size by Application (2015-2020)
- 5.1.1 Global Durvalumab Sales by Application (2015-2020)
- 5.1.2 Global Durvalumab Revenue by Application (2015-2020)
- 5.1.3 Durvalumab Price by Application (2015-2020)
- 5.2 Durvalumab Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Durvalumab Sales Forecast by Application (2021-2026)
- 5.2.2 Global Durvalumab Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Durvalumab Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Durvalumab by Country
- 6.1.1 North America Durvalumab Sales by Country
- 6.1.2 North America Durvalumab Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Durvalumab Market Facts & Figures by Type
- 6.3 North America Durvalumab Market Facts & Figures by Application
7 Europe
- 7.1 Europe Durvalumab by Country
- 7.1.1 Europe Durvalumab Sales by Country
- 7.1.2 Europe Durvalumab Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Durvalumab Market Facts & Figures by Type
- 7.3 Europe Durvalumab Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Durvalumab by Region
- 8.1.1 Asia Pacific Durvalumab Sales by Region
- 8.1.2 Asia Pacific Durvalumab Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Durvalumab Market Facts & Figures by Type
- 8.3 Asia Pacific Durvalumab Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Durvalumab by Country
- 9.1.1 Latin America Durvalumab Sales by Country
- 9.1.2 Latin America Durvalumab Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Durvalumab Market Facts & Figures by Type
- 9.3 Central & South America Durvalumab Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Durvalumab by Country
- 10.1.1 Middle East and Africa Durvalumab Sales by Country
- 10.1.2 Middle East and Africa Durvalumab Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Durvalumab Market Facts & Figures by Type
- 10.3 Middle East and Africa Durvalumab Market Facts & Figures by Application
11 Company Profiles
- 11.1 Medimmune (AstraZeneca)
- 11.1.1 Medimmune (AstraZeneca) Corporation Information
- 11.1.2 Medimmune (AstraZeneca) Description, Business Overview and Total Revenue
- 11.1.3 Medimmune (AstraZeneca) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
- 11.1.5 Medimmune (AstraZeneca) Recent Development
- 11.1 Medimmune (AstraZeneca)
- 11.1.1 Medimmune (AstraZeneca) Corporation Information
- 11.1.2 Medimmune (AstraZeneca) Description, Business Overview and Total Revenue
- 11.1.3 Medimmune (AstraZeneca) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
- 11.1.5 Medimmune (AstraZeneca) Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Durvalumab Market Estimates and Projections by Region
- 12.1.1 Global Durvalumab Sales Forecast by Regions 2021-2026
- 12.1.2 Global Durvalumab Revenue Forecast by Regions 2021-2026
- 12.2 North America Durvalumab Market Size Forecast (2021-2026)
- 12.2.1 North America: Durvalumab Sales Forecast (2021-2026)
- 12.2.2 North America: Durvalumab Revenue Forecast (2021-2026)
- 12.2.3 North America: Durvalumab Market Size Forecast by Country (2021-2026)
- 12.3 Europe Durvalumab Market Size Forecast (2021-2026)
- 12.3.1 Europe: Durvalumab Sales Forecast (2021-2026)
- 12.3.2 Europe: Durvalumab Revenue Forecast (2021-2026)
- 12.3.3 Europe: Durvalumab Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Durvalumab Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Durvalumab Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Durvalumab Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Durvalumab Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Durvalumab Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Durvalumab Sales Forecast (2021-2026)
- 12.5.2 Latin America: Durvalumab Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Durvalumab Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Durvalumab Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Durvalumab Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Durvalumab Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Durvalumab Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Durvalumab Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Durvalumab Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Durvalumab. Industry analysis & Market Report on COVID-19 Impact on Global Durvalumab is a syndicated market report, published as COVID-19 Impact on Global Durvalumab Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Durvalumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
